Abstract

The U12-dependent (minor) spliceosome excises a rare group of introns that are characterized by a highly conserved 5′ splice site and branch point sequence. Several new congenital or somatic diseases have recently been associated with mutations in components of the minor spliceosome. A common theme in these diseases is the detection of elevated levels of transcripts containing U12-type introns, of which a subset is associated with other splicing defects. Here we review the present understanding of minor spliceosome diseases, particularly those associated with the specific components of the minor spliceosome. We also present a model for interpreting the molecular-level consequences of the different diseases.

Highlights

  • Pre-mRNA splicing is an essential step in the gene expression pathway of all eukaryotes

  • Three of them affect the components of the U11/U12 disnRNP, namely the U11/U12-65K protein (RNPC3; [27]), U12 small nuclear RNA (snRNA) (RNU12; [28]) and Urp protein (ZRSR2; [29]); while two diseases are attributed to mutations in the U4atac snRNA (RNU4ATAC; [30,31,32])

  • Apart from mutations in the core minor spliceosome components, we describe the few reported human diseases caused by mutations at the splice sites of U12-type introns, though we note that this appears to be underexplored territory given the small number of cases reported so far

Read more

Summary

Introduction

Pre-mRNA splicing is an essential step in the gene expression pathway of all eukaryotes. U12-type introns are enriched in genes that represent a rather restricted set of functional classes and pathways They are present in genes related to ‘information processing functions’, such as DNA replication and repair, transcription, RNA processing, and translation, but can be found in genes related to cytoskeletal organization, vesicular transport, and voltage-gated ion channel activity, as suggested originally by Burge et al, [12] and verified later [13,14]. U11/U12 di-snRNP protein component, Urp/ZRSR2 takes up the role of 3 ss recognition with minor introns [19] Following this initial recognition, both splicing pathways proceed with association of a tri-snRNP, either U4atac/U6atac.U5 or U4/U6.U5 (Fig. 1B; [20,21]). Those have been discussed in detail elsewhere [24]

Minor spliceosome in human disease
Diseases affecting the intron recognition step
Diseases affecting the formation of catalytically active spliceosome
Other spliceosome mutations affecting minor spliceosome activity
Diseases with mutations in the U12-type splice sites
Minor spliceosome components as biomarkers
Consequences of minor spliceosome-specific mutations
The fate of the mRNA: intron retention vs cryptic splicing
Fate of the mRNA and disease severity
Defects with individual genes vs a global splicing defect
Findings
Future perspective
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.